4//SEC Filing
Campbell Chad Thomas 4
Accession 0001140361-23-036320
CIK 0001275187other
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 9:32 PM ET
Size
8.9 KB
Accession
0001140361-23-036320
Insider Transaction Report
Form 4
Campbell Chad Thomas
SVP/GM, Vascular Access
Transactions
- Exercise/Conversion
Common Stock
2023-07-19+3,900→ 51,409 total - Tax Payment
Common Stock
2023-07-19$8.92/sh−1,404$12,524→ 50,005 total - Exercise/Conversion
Performance Right
2023-07-19−13,453→ 0 total→ Common Stock (13,453 underlying)
Footnotes (3)
- [F1]This acquisition of 3,900 shares of Common Stock ("Common Stock") of AngioDynamics, Inc. ("AngioDynamics") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020.
- [F2]The exempt disposition of 1,404 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020.
- [F3]On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited.
Documents
Issuer
ANGIODYNAMICS INC
CIK 0001275187
Entity typeother
Related Parties
1- filerCIK 0001706852
Filing Metadata
- Form type
- 4
- Filed
- Jul 25, 8:00 PM ET
- Accepted
- Jul 26, 9:32 PM ET
- Size
- 8.9 KB